Cargando…
Elevated Factor VIII and von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis
INTRODUCTION: Plasma factor VIII (FVIII) and von Willebrand factor (VWF) levels have been associated with the rate and severity of arterial thrombus formation and have been linked to outcomes following thrombolytic therapy in acute myocardial infarction patients. Here, we aimed to investigate FVIII...
Autores principales: | Tóth, Noémi Klára, Székely, Edina Gabriella, Czuriga-Kovács, Katalin Réka, Sarkady, Ferenc, Nagy, Orsolya, Lánczi, Levente István, Berényi, Ervin, Fekete, Klára, Fekete, István, Csiba, László, Bagoly, Zsuzsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787073/ https://www.ncbi.nlm.nih.gov/pubmed/29410644 http://dx.doi.org/10.3389/fneur.2017.00721 |
Ejemplares similares
-
Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
por: Székely, Edina Gabriella, et al.
Publicado: (2022) -
A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis
por: Orbán-Kálmándi, Rita, et al.
Publicado: (2021) -
PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients
por: Szegedi, István, et al.
Publicado: (2019) -
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis
por: Szegedi, István, et al.
Publicado: (2021) -
Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients
por: Székely, Edina Gabriella, et al.
Publicado: (2018)